Literature DB >> 15855740

Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse.

Markus J Kemper1, Kristina Zepf, Ilka Klaassen, Amrey Link, Dirk E Muller-Wiefel.   

Abstract

BACKGROUND/AIM: Although clinical and immunological findings in steroid-sensitive nephrotic syndrome (SSNS) favor an immunopathogenesis, many issues remain unsolved. Comprehensive studies analyzing cellular and humoral immunity in SSNS are scarce, and few studies addressed the effect of steroids on immunological factors.
METHODS: We therefore performed a cross-sectional study of T and B lymphocyte populations in 89 children during the different stages of the disease and related the findings to parameters of humoral immunity and treatment with steroids.
RESULTS: In untreated relapse, an increase in the proportion of activated CD3+ lymphocytes with a concomitant reduction of CD19+ B cells was noted compared to healthy controls. Conversely, patients with steroid dependency, relapsing on alternate-day steroids, showed a decline of the absolute numbers as well as proportion of CD4+ lymphocytes but a relative increase in CD19+ B cells, compared to healthy controls. Also untreated remission was characterized by an absolute and relative decrease in CD4+ lymphocytes compared to healthy controls which was accompanied by a significant increase in the proportion of CD8+ and also activated CD3+ lymphocytes. Steroid-induced remission resulted in suppression of absolute and relative CD4+, while absolute and relative B cells were upregulated in this group compared to untreated remission. SUMMARY AND
CONCLUSION: Alterations of lymphocyte populations in SSNS are not limited to relapse but seem to be more pronounced in remission and show a different profile with steroid treatment. Changes of lymphocyte populations do not only affect T but also B lymphocytes, which may be of relevance in the pathogenesis of this disorder. 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855740     DOI: 10.1159/000085357

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  16 in total

Review 1.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

Review 2.  Rituximab and minimal change nephrotic syndrome: a therapeutic option.

Authors:  Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-05-26       Impact factor: 2.801

3.  Characterisation of renal immune cell infiltrates in children with nephrotic syndrome.

Authors:  Kerstin Benz; Maike Büttner; Katalin Dittrich; Valentina Campean; Jörg Dötsch; Kerstin Amann
Journal:  Pediatr Nephrol       Date:  2010-04-13       Impact factor: 3.714

4.  Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.

Authors:  Rodney D Gilbert; Eleanor Hulse; Susan Rigden
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

Review 5.  Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?

Authors:  Jörg Dötsch; Dirk E Müller-Wiefel; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

6.  Prevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom.

Authors:  Miao Zhang; Hong Luan; Qian Zhang; Le Wang; Yong-Man Lv; Fan He; Yan Chen; Hong-Bing Zeng; Ying Yao; Qin Liu
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

Review 7.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

Review 8.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

9.  The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.

Authors:  Hatice Ezgi Baris; Safa Baris; Elif Karakoc-Aydiner; Ibrahim Gokce; Nurdan Yildiz; Dilek Cicekkoku; Ismail Ogulur; Ahmet Ozen; Harika Alpay; Isil Barlan
Journal:  Eur J Pediatr       Date:  2016-01-30       Impact factor: 3.183

10.  Tuberculosis infection in children with proteinuria/nephrotic syndrome.

Authors:  Hanna Szymanik-Grzelak; Elżbieta Kuźma-Mroczkowska; Piotr Skrzypczyk; Teresa Bielecka; Iwona Kotula; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2017-10-30       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.